The Drug Enforcement Agency (DEA) announced the extension of many telemedicine flexibilities adopted during the COVID-19 PHE. The announcement includes proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 public health emergency.
DEA Press Release